RxDoctor Payments DataLook up a doctor →

Arpit Rao

Hematology & Oncology · Minneapolis, MNNPI 1982991170

Payments from drug & device makers

$1,584,071in general payments, 2019–2025

Across 485 payments — averaging $3266.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$564K
  • Clovis Oncology, Inc.$356K
  • Eli Lilly$285K
  • Seagen Inc.$282K
  • E.r. Squibb & Sons, L.L.C.$64K
  • Pfizer$18K
  • plus $15K from 12 others
$14,633in research payments, 2019–2025

Across 2 payments — averaging $7316.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$15K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,584,071 in reported general payments places this provider in the 90th percentile of 193 hematology & oncology providers in Minnesota.

See all hematology & oncology providers in Minnesota

Other hematology & oncology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →